| Literature DB >> 17408390 |
K Raj1, A Ho, J D Creamer, A W P du Vivier, J R Salisbury, G J Mufti.
Abstract
Cutaneous manifestations of myelodysplastic syndromes (MDS) may predict disease progression and a poorer prognosis. We describe a patient in whom a deep neutrophilic dermatosis preceded evolution of disease from refractory anaemia to RAEB (refractory anaemia with excess blasts) and resolved completely on treating the disease with 5-azacytidine. The dermatological response was accompanied by complete bone marrow remission and trilineage haematological improvement. We suggest that 5-azacytidine should be considered in the treatment of immune mediated cutaneous manifestations of MDS.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17408390 DOI: 10.1111/j.1365-2133.2007.07831.x
Source DB: PubMed Journal: Br J Dermatol ISSN: 0007-0963 Impact factor: 9.302